Follow this preprint
Cardiac magnetic resonance markers of pre-clinical hypertrophic and dilated cardiomyopathy in genetic variant carriers
View ORCID ProfilePhilip M. Croon, View ORCID ProfileMarion van Vugt, View ORCID ProfileCornelis P. Allaart, View ORCID ProfileBram Ruijsink, View ORCID ProfilePerry M. Elliott, View ORCID ProfileFolkert W. Asselbergs, View ORCID ProfileRohan Khera, View ORCID ProfileConnie R. Bezzina, View ORCID ProfileMichiel Winter, View ORCID ProfileA. Floriaan Schmidt
doi: https://doi.org/10.1101/2024.11.15.24317368
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Philip M. Croon
1Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
2Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
Marion van Vugt
1Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
3Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, Amsterdam, The Netherlands
4Division Heart & Lungs, Department of Cardiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
5Institute of Cardiovascular Science, Faculty of Population Health, University College London, London, United Kingdom
Cornelis P. Allaart
1Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
Bram Ruijsink
4Division Heart & Lungs, Department of Cardiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
6School of Biomedical Engineering & Imaging Sciences, King’s College London, London, United Kingdom
Perry M. Elliott
7Barts Heart Centre, St. Bartholomew’s Hospital, London, United Kingdom
8Centre for Heart Muscle Disease, Institute of Cardiovascular Science, University College London, London, United Kingdom
Folkert W. Asselbergs
1Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
9Institute of Health Informatics, University College London, London, UK
10National Institute for Health Research, University College London Hospitals, Biomedical Research Centre, University College London, London, UK
Rohan Khera
2Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
11Section of Health Informatics, Department of Biostatistics, Yale School of Public Health, New Haven, CT
12Section of Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, CT
13Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT
Connie R. Bezzina
3Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, Amsterdam, The Netherlands
14Department of Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
Michiel Winter
1Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
A. Floriaan Schmidt
1Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
3Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, Amsterdam, The Netherlands
4Division Heart & Lungs, Department of Cardiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
5Institute of Cardiovascular Science, Faculty of Population Health, University College London, London, United Kingdom
15UCL British Heart Foundation Research Accelerator, London, United Kingdom

- Supplementary Tables[supplements/317368_file03.xlsx]
- Supplementary Materials[supplements/317368_file04.pdf]
Posted November 15, 2024.
Cardiac magnetic resonance markers of pre-clinical hypertrophic and dilated cardiomyopathy in genetic variant carriers
Philip M. Croon, Marion van Vugt, Cornelis P. Allaart, Bram Ruijsink, Perry M. Elliott, Folkert W. Asselbergs, Rohan Khera, Connie R. Bezzina, Michiel Winter, A. Floriaan Schmidt
medRxiv 2024.11.15.24317368; doi: https://doi.org/10.1101/2024.11.15.24317368
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (413)
- Allergy and Immunology (727)
- Anesthesia (215)
- Cardiovascular Medicine (3121)
- Dermatology (264)
- Emergency Medicine (464)
- Epidemiology (13070)
- Forensic Medicine (14)
- Gastroenterology (867)
- Genetic and Genomic Medicine (4885)
- Geriatric Medicine (449)
- Health Economics (753)
- Health Informatics (3084)
- Health Policy (1109)
- Hematology (410)
- HIV/AIDS (969)
- Medical Education (456)
- Medical Ethics (121)
- Nephrology (502)
- Neurology (4659)
- Nursing (248)
- Nutrition (691)
- Oncology (2404)
- Ophthalmology (683)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (309)
- Palliative Medicine (88)
- Pathology (518)
- Pediatrics (1249)
- Primary Care Research (525)
- Public and Global Health (7218)
- Radiology and Imaging (1612)
- Respiratory Medicine (945)
- Rheumatology (462)
- Sports Medicine (403)
- Surgery (516)
- Toxicology (65)
- Transplantation (222)
- Urology (192)